Mike Havrilla
Mike Havrilla
Send Message
Mike Havrilla
Stop FollowingMike Havrilla
ABOUT
Mike Havrilla is a pharmacist, marathon runner, biotech stock trader and writer with experience that includes licensed pharmacist since January 2004, online investing since August 1997 and writing for investors since April 2007. Mike holds Doctor of Pharmacy and Bachelor of Science (Biology) degrees from the University of Pittsburgh and worked in the pharmaceutical industry for Wyeth prior to pharmacy school. He is also an avid runner and has completed over 20 marathons with a personal best time under three hours for the 26.2 mile race. Mike merged his former publishing business with BioRunUp.com / Mark Messier in October 2010, creating a new online biotech stock research and trading subscription service.
SNAPSHOT
- Description: Newsletter author. Trading frequency: Daily
- Interests: Stocks - long
COMPANY
BioRunUp.com BioRunUp.com has evolved into an informed biotech stock trading community seeking to generate consistent profits in any market condition through a variety of long, short and options-based strategies.
BLOG
Twitter @mikehavrilla
Pharmacist (@PittPharmacy Grad). Biotech Stock Trader & Writer. Black & Yellow Sports Fan. Marathon Runner. Woodsman.
LATEST STOCKTALK
more »
I just joined LinkedIn and created my professional profile. Join my network. http://lnkd.in/n32H-8
Jun 9, 2013
Latest Comments
more »
- CT scan is the gold standar... on Venaxis Poised For Run-Up Into Pivotal Study Re...
- They expect to make initial... on Venaxis Poised For Run-Up Into Pivotal Study Re...
- forgot to embed the six-mon... on Nymox Pharma: Developing A Potential Long-Term ...
- tax loss selling is possibl... on Anika Therapeutics: Growth Stock At Value Price...
- I guess we will find out ne... on Amicus Therapeutics Poised For Rebound Into Dec...
Latest comments on Mike's Articles
- yellowtailcheek on ThermoGenesis: Multiple Catalysts Could Heat Up...
- RetireInTheSunshine on Venaxis Poised For Run-Up Into Pivotal Study Re...
- Steve Russell on ThermoGenesis: Multiple Catalysts Could Heat Up...
- RetireInTheSunshine on Venaxis Poised For Run-Up Into Pivotal Study Re...
- xdwingdx on Flamel: Near-Term, Under The Radar FDA Catalyst...
LATEST ARTICLES & INSTAPOSTS
more »



